- Red or tiger top, or clot activator tube
- 5 mL of venous blood
Additional information
- Serial sampling is preferred at 0, 6, and 12 hrs after onset of chest pain
- Record date and time of each sample
- Send to lab immediately
Overview of Cardiac Enzymes
- Cardiac troponins (T and I) are specific markers of myocardial damage.
- Each medical facility usually utilizes one of these troponins (T or I) in conjunction with CK and CK-MB testing as part of their cardiac enzyme order set.
- It is typical to order a baseline, 6 hr and 12 hr level of a cardiac specific troponin, CK and CK-MB.
Information on Troponin T testing
- The troponin T (cTnT) test measures the concentration of cardiac troponin T subtype in the blood.
- Troponins are a complex group of three contractile proteins (C, T and, I) which regulate the interaction of actin and myosin in cardiac and skeletal muscle.
- Though structurally the cardiac and skeletal subforms of Troponin C are identical, Troponin T and I have distinct cardiac and skeletal subforms which can be identified by specific assay. Hence Troponin I and T are highly cardiospecific.
- Approximately 2% of cTnI and 6% of cTnT are free in the myocardial cytoplasm.
- Myocardial injury or necrosis results in release of cardiac troponins into the bloodstream as early as 2-6 hrs.
- Troponin T is typically positive within 2-6 hours after cardiac injury and returns to baseline within 10-14 days.
- Troponin T levels peak within 15-24 hours.
- cTnT can be analyzed by both qualitative (bedside, point of care) and quantitative assays.
The clinical utility of the serum troponin T test includes:
- Detects myocardial injury (hours after it has occurred)
- Used in the evaluation and diagnosis of chest pain
- Aids in the diagnosis of acute myocardial infarction (AMI) & acute coronary syndrome (ACS)
- Is a sensitive marker for unstable angina
- For detection of perfusion following thrombolysis
- As a prognostic marker and for risk stratification in acute coronary syndromes (ACS)
- To monitor for perioperative myocardial infarction
- For diagnosis of cardiac contusion
- For excluding cardiac injury during electroconversion
- As a biomarker in drug induced cardiotoxicity
- Found to be a prognostic indicator of mortality risk in patients with acute decompensated heart failure (a positive result – 8% mortality versus 2.7% mortality in patients with a negative result)
Advantages of cardiac troponin T test include:
- Better specificity and sensitivity for cardiac damage than CK-MB
- Aids in the early detection of small myocardial infarcts that are undetectable by conventional diagnostic methods
- Detects cardiac damage that has occurred in the past 2 weeks, since it remains elevated for 10-14 days after injury
- cTnT is more sensitive for the diagnosis of acute myocardial infarction than creatinine phosphokinase MB fraction (CK-MB), myoglobin and lactate dehydrogenase (LDH) isoenzymes
- The serum concentration of cTnT is in direct proportion to the extent of myocardial injury
- Troponin T is more sensitive but less specific in comparison to troponin I
Disadvantages of this test include:
- Troponin T may cross-react with troponin found in other muscles and give positive or increased results in the absence of heart damage
- Cardiac troponins have the disadvantage of not being as useful for monitoring for reinfarction due to their prolonged elevation following myocardial injury (one should utilize CK-MB for this purpose)
- Troponin T is more sensitive but less specific in comparison to troponin I
Additional information
- Myocardial injury or necrosis results in release of cardiac troponins into the bloodstream as early as 2-6 hrs.
- Troponin T is typically positive within 2-6 hours after cardiac injury and returns to baseline within 10-14 days.
- Troponin T levels peak within 15-24 hours.
- Cardiac troponins are ideal biomarkers for evaluation of ACS in patients with coexistent skeletal muscle injury
- Falsely elevated troponin T levels are seen in hemodialysis patients, because of uremic myopathy
- Elevated troponins in uremic patients has been shown to be a poor prognostic factor for survival
- Related laboratory tests include:
- Apolipoprotein A and B
- Aspartate aminotransferase
- Atrial natriuretic peptide
- Blood gases
- B-type natriuretic peptide
- C-reactive protein
- Creatine kinase and isoenzymes
- Electrolytes
- Lactate dehydrogenase and isoenzymes
- Lipid profile
- Lipoprotein electrophoresis
- Myoglobin
Consult your laboratory for their normal ranges as these will probably vary somewhat from the ones listed below.
| Conv. Units (ng/mL) | SI Units (µg/L) | |
|---|---|---|
| Normal | <0.03 | <0.03 |
| Suggestive of cardiac injury | >0.1 | >0.1 |
Conditions associated with elevated cTnT values include:
- Acute myocardial infarction (AMI)
- Acute coronary syndrome (ACS) or unstable angina
- Myocardial damage after:
- Coronary artery bypass graft surgery
- Other cardiac procedures
- Percutaneous transluminal coronary angioplasty (PTCA)
- Cardiac contusion or trauma
- Cardiac amyloidosis
- Defibrillation
- Nonischemic dilated or hypertrophic cardiomyopathy
- Myocarditis
- Radiofrequency ablation
- Non cardiac causes:
- Chronic renal failure
- Critical illness such as sepsis
- Patients on hemodialysis
- Primary pulmonary hypertension
- Pulmonary embolism
- Scorpion envenomation
- Stroke (especially SAH)
- Very heavy exercise as in marathon
- Drugs
-Sympathomimetics- Anthracyclines
- Antineoplastics
- Doxorubicin
- Heparin
- Abasi A et al. Cardiac troponins T and I in patients with end-stage renal disease: the relation with left ventricular mass and their prognostic value. Clin Cardiol. 2004 Dec;27(12):704-9.
- Ammann et al. Raised cardiac troponins. BMJ. 2004;328:1028-1029 (1 May), doi:10.1136/bmj.328.7447.1028.
- Clark SJ et al. Cardiac troponin T in cord blood. Arch Dis Child Fetal Neonatal Ed. 2001 Jan;84(1):F34-7.
- Dinckal MH et al. Acute rest perfusion imaging in high risk unstable angina: association with troponin T and clinical endpoints. Int J Cardiovasc Imaging. 2003 Dec;19(6):511-7.
- eMedicine from WebMD®. Use of Cardiac Markers in the Emergency Department. [Homepage on the Internet] ©1996-2006. Last updated on June 26, 2006. Last accessed on November 29, 2006. Available at URL: http://www.emedicine.com/emerg/topic932.htm
- Goodacre S et al. Which diagnostic tests are most useful in a chest pain unit protocol? BMC Emerg Med. 2005 August 25; 5:6.
- LabTestsOnline®. Troponin. [Homepage on the Internet] ©2001-2006. Last reviewed on September 7 13, 2005. Last accessed on November 13, 2006. Available at URL: http://www.labtestsonline.org/understanding/analytes/troponin/test.html
- Makikallio K et al. Association of severe placental insufficiency and systemic venous pressure rise in the fetus with increased neonatal cardiac troponin T levels. Am J Obstet Gynecol. 2000 Sep;183(3):726-31.
- Peacock WF, et al. Cardiac Troponin and Outcome in Acute Heart Failure. NEJM. 2008 May 15;358(20):2117-26.
- Perna ER et al. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. Int J Cardiol. 2005 Mar 18;99(2):253-61.
- Pruszczyk P et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest. 2003 Jun;123(6):1947-52.
- StorrowAB, Lindsell CJ, Han J, et al. Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain. Annals of Emergency Medicine,2006 Dec; 48(6):660-5. Epub 2006 Aug 14.